PROLONGED TREATMENT OR SKIN ABSORPTION OF LARGE QUANTITIES MAY BE HARMFUL.
MAY BE HARMFUL IF SWALLOWED
MAY PRODUCE AN ALLERGIC REACTION
MAY CAUSE SKIN IRRITATION AND/OR DERMATITIS
OCCUPATIONAL RESTRICTIONS FOR PREGNANT AND BREAST FEEDING WOMEN

APPEARANCE: OFF-WHITE

PHYSICAL STATE: SEMI-SOLID OINTMENT.

ODOR: NO INFORMATION AVAILABLE

POTENTIAL HEALTH EFFECTS:

ACUTE TOXICITY:

EYES: MAY CAUSE IRRITATION.

SKIN:
PROLONGED TREATMENT OR SKIN ABSORPTION OF LARGE QUANTITIES MAY BE HARMFUL.
MAY CAUSE SKIN IRRITATION AND/OR DERMATITIS. REPEATED OR PROLONGED SKIN
CONTACT MAY CAUSE ALLERGIC REACTIONS WITH SUSCEPTIBLE PERSONS.

INHALATION: NOT AN EXPECTED ROUTE OF EXPOSURE.

INGESTION:
NOT AN EXPECTED ROUTE OF EXPOSURE. DO NOT INGEST. MAY BE HARMFUL IF
SWALLOWED. INGESTION MAY CAUSE GASTROINTESTINAL IRRITATION, NAUSEA,
VOMITING AND DIARRHEA.

CHRONIC EFFECTS:
PROLONGED TREATMENT OR SKIN ABSORPTION OF LARGE QUANTITIES MAY BE HARMFUL.
MAY PRODUCE AN ALLERGIC REACTION. MAY CAUSE ADVERSE LIVER AND KIDNEY
EFFECTS. CONTAINS A KNOWN OR SUSPECTED REPRODUCTIVE TOXIN.

NURSING MOTHERS:
THERE ARE NO DATA ON THE EXCRETION OF NEOMYCIN, AN AMINOGLYCOSIDE INTO
HUMAN MILK. OTHER AMINOGLYCOSIDES ARE EXCRETED INTO HUMAN MILK.

PRODUCT INFORMATION:
PROLONGED TREATMENT OR SKIN ABSORPTION OF LARGE QUANTITIES MAY BE HARMFUL.
MAY BE HARMFUL IF SWALLOWED. MAY CAUSE EYE AND SKIN IRRITATION.

CHEMICAL NAME LD50 ORAL LD50 DERMAL LC50 INHALATION

PETROLATUM (USP GRADE) >3600 MG/KG (RABBIT)

CHRONIC TOXICITY:

CHRONIC TOXICITY:
PROLONGED TREATMENT OR SKIN ABSORPTION OF LARGE QUANTITIES MAY BE HARMFUL.
MAY PRODUCE AN ALLERGIC REACTION. MAY CAUSE ADVERSE LIVER AND KIDNEY
EFFECTS. CONTAINS A KNOWN OR SUSPECTED REPRODUCTIVE TOXIN.

NURSING MOTHERS:
THERE ARE NO DATA ON THE EXCRETION OF NEOMYCIN, AN AMINOGLYCOSIDE INTO
HUMAN MILK. OTHER AMINOGLYCOSIDES ARE EXCRETED INTO HUMAN MILK.

DEVELOPMENTAL TOXICITY:
NEOMYCIN HAS BEEN ASSIGNED TO PREGNANCY CATEGORY D (THERE IS POSITIVE
EVIDENCE OF HUMAN FETAL RISK BASED ON ADVERSE REACTION DATA FROM
INVESTIGATIONAL OR MARKETING EXPERIENCE OR STUDIES IN HUMANS, BUT POTENTIAL
BENEFITS MAY WARRANT USE OF THE DRUG IN PREGNANT WOMEN DESPITE POTENTIAL
RISKS.)

WASTE DISPOSAL METHODS:
THIS MATERIAL, AS SUPPLIED, IS NOT A HAZARDOUS WASTE ACCORDING TO FEDERAL
REGULATIONS (40 CFR 261). THIS MATERIAL COULD BECOME A HAZARDOUS WASTE IF
IT IS MIXED WITH OR OTHERWISE COMES IN CONTACT WITH A HAZARDOUS WASTE, IF
CHEMICAL ADDITIONS ARE MADE TO THIS MATERIAL, OR IF THE MATERIAL IS
PROCESSED OR OTHERWISE ALTERED. CONSULT 40 CFR 261 TO DETERMINE WHETHER THE
ALTERED MATERIAL IS A HAZARDOUS WASTE. CONSULT THE APPROPRIATE STATE,
REGIONAL, OR LOCAL REGULATIONS FOR ADDITIONAL REQUIREMENTS.

CONTAMINATED PACKAGING: DO NOT RE-USE EMPTY CONTAINERS.

CALIFORNIA HAZARDOUS WASTE CODES: 311

CALIFORNIA WASTE CODE LEGEND: PHARMACEUTICAL WASTE

THIS PRODUCT CONTAINS ONE OR MORE SUBSTANCES THAT ARE LISTED WITH THE STATE
OF CALIFORNIA AS A HAZARDOUS WASTE.

U.S. FEDERAL REGULATIONS:
SECTION 313 OF TITLE III OF THE SUPERFUND AMENDMENTS AND REAUTHORIZATION
ACT OF 1986 (SARA). THIS PRODUCT DOES NOT CONTAIN ANY CHEMICALS WHICH ARE
SUBJECT TO THE REPORTING REQUIREMENTS OF THE ACT AND TITLE 40 OF THE CODE
OF FEDERAL REGULATIONS, PART 372.

THIS IS AN FDA REGULATED PRODUCT AND AS SUCH IS EXEMPTED FROM SARA TIER II
REPORTING.

CLEAN WATER ACT:
THIS PRODUCT DOES NOT CONTAIN ANY SUBSTANCES REGULATED AS POLLUTANTS
PURSUANT TO THE CLEAN WATER ACT (40 CFR 122.21 AND 40 CFR 122.42).

CERCLA:
THIS MATERIAL, AS SUPPLIED, DOES NOT CONTAIN ANY SUBSTANCES REGULATED AS
HAZARDOUS SUBSTANCES UNDER THE COMPREHENSIVE ENVIRONMENTAL RESPONSE
COMPENSATION AND LIABILITY ACT (CERCLA) (40 CFR 302) OR THE SUPERFUND
AMENDMENTS AND REAUTHORIZATION ACT (SARA) (40 CFR 355). THERE MAY BE
SPECIFIC REPORTING REQUIREMENTS AT THE LOCAL, REGIONAL, OR STATE LEVEL
PERTAINING TO RELEASES OF THIS MATERIAL.

U.S. STATE REGULATIONS:

CALIFORNIA PROPOSITION 65:

THIS PRODUCT CONTAINS THE FOLLOWING PROPOSITION 65 CHEMICALS:

CHEMICAL NAME CAS-NO CALIFORNIA PROP. 65

NEOMYCIN SULFATE USP MICRONIZED 1405-10-3 DEVELOPMENTAL

U.S. STATE RIGHT-TO-KNOW REGULATIONS:
"X" DESIGNATES THAT THE INGREDIENTS ARE LISTED ON THE STATE RIGHT TO KNOW
LIST.

CANADA:
THIS PRODUCT IS REGULATED BY THE FOOD AND DRUG ADMINISTRATION OF HEALTH
CANADA AND IS NOT SUBJECT TO THE WHMIS REQUIREMENTS OF THE HAZARDOUS
PRODUCTS ACT AND THE CONTROLLED PRODUCTS REGULATIONS.

GENERAL DISCLAIMER:
THE INFORMATION PROVIDED ON THIS MSDS IS CORRECT TO THE BEST OF OUR
KNOWLEDGE, INFORMATION AND BELIEF AT THE DATE OF ITS PUBLICATION. THE
INFORMATION GIVEN IS DESIGNED ONLY AS A GUIDE FOR SAFE HANDLING, USE,
PROCESSING, STORAGE, TRANSPORTATION, DISPOSAL AND RELEASE AND IS NOT TO BE
CONSIDERED AS A WARRANTY OR QUALITY SPECIFICATION. THE INFORMATION RELATES
ONLY TO THE SPECIFIC MATERIAL DESIGNATED AND MAY NOT BE VALID FOR SUCH
MATERIAL USED IN COMBINATION WITH ANY OTHER MATERIAL OR IN ANY PROCESS,
UNLESS SPECIFIED IN THE TEXT.